Moderna’s Covid-19 Vaccine Is 94.5% Effective in Early Results, Firm Says
Moderna’s experimental coronavirus vaccine was 94.5% effective at protecting people from symptomatic Covid-19, an early look at pivotal study results showed—the second vaccine to hit a key milestone.